Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy.

Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Silva GV, Mesquita CT, Belém L, Vaughn WK, Rangel FO, Assad JA, Carvalho AC, Branco RV, Rossi MI, Dohmann HJ, Willerson JT.

Circulation. 2004 Sep 14;110(11 Suppl 1):II213-8.

2.

Intracoronary stem cell infusion in heart transplant candidates.

Yelda T, Berrin U, Murat S, Aytac O, Sevgi B, Yasemin S, Ayşe M, Deniz S, Yilmaz N.

Tohoku J Exp Med. 2007 Oct;213(2):113-20.

3.

Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.

Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Carvalho AC, Dutra HS, Dohmann HJ, Silva GV, Belém L, Vivacqua R, Rangel FO, Esporcatte R, Geng YJ, Vaughn WK, Assad JA, Mesquita ET, Willerson JT.

Circulation. 2003 May 13;107(18):2294-302. Epub 2003 Apr 21.

4.

Five-year follow-up after transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy.

Akar AR, Durdu S, Arat M, Kilickap M, Kucuk NO, Arslan O, Kuzu I, Ozyurda U.

Eur J Cardiothorac Surg. 2009 Oct;36(4):633-43. doi: 10.1016/j.ejcts.2009.04.045. Epub 2009 Jun 12.

PMID:
19524451
5.

Catheter-based transendocardial delivery of autologous bone-marrow-derived mononuclear cells in patients listed for heart transplantation.

Silva GV, Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Assad JA, Vaughn WK, Mesquita CT, Belém L, Carvalho AC, Dohmann HJ, Barroso do Amaral E, Coutinho J, Branco R, Oliveira E, Willerson JT.

Tex Heart Inst J. 2004;31(3):214-9.

6.

Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure.

Perin EC, Silva GV, Zheng Y, Gahremanpour A, Canales J, Patel D, Fernandes MR, Keller LH, Quan X, Coulter SA, Moore WH, Herlihy JP, Willerson JT.

Am Heart J. 2012 Mar;163(3):415-21, 421.e1. doi: 10.1016/j.ahj.2011.11.020. Epub 2012 Feb 10.

PMID:
22424012
7.

Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease.

Fuchs S, Kornowski R, Weisz G, Satler LF, Smits PC, Okubagzi P, Baffour R, Aggarwal A, Weissman NJ, Cerqueira M, Waksman R, Serrruys P, Battler A, Moses JW, Leon MB, Epstein SE.

Am J Cardiol. 2006 Mar 15;97(6):823-9. Epub 2006 Jan 30.

PMID:
16516583
8.

[Intracoronary autologous bone marrow-derived stem cell transplantation in patients with ischemic cardiomyopathy: results of 18-month follow-up].

Tayyareci Y, Umman B, Sezer M, Beşişik S, Sanli Y, Mudun A, Gürses N, Nişanci Y.

Turk Kardiyol Dern Ars. 2008 Dec;36(8):519-29. Turkish.

9.

Impact of intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction on left ventricular perfusion and function: a 6-month follow-up gated 99mTc-MIBI single-photon emission computed tomography study.

Lipiec P, Krzemińska-Pakuła M, Plewka M, Kuśmierek J, Płachcińska A, Szumiński R, Robak T, Korycka A, Kasprzak JD.

Eur J Nucl Med Mol Imaging. 2009 Apr;36(4):587-93. doi: 10.1007/s00259-008-0988-6. Epub 2008 Nov 29.

PMID:
19050877
10.

Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction.

Chen SL, Fang WW, Qian J, Ye F, Liu YH, Shan SJ, Zhang JJ, Lin S, Liao LM, Zhao RC.

Chin Med J (Engl). 2004 Oct;117(10):1443-8. Erratum in: Chin Med J (Engl). 2005 Jan 5;118(1):88.

PMID:
15498362
11.

Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy.

Gao LR, Wang ZG, Zhu ZM, Fei YX, He S, Tian HT, Zhang NK, Chen Y, Xu HT, Yang Y.

Am J Cardiol. 2006 Sep 1;98(5):597-602. Epub 2006 Jun 30.

PMID:
16923443
12.

Transendocardial autologous bone marrow in chronic myocardial infarction using a helical needle catheter: 1-year follow-up in an open-label, nonrandomized, single-center pilot study (the TABMMI study).

de la Fuente LM, Stertzer SH, Argentieri J, Peñaloza E, Miano J, Koziner B, Bilos C, Altman PA.

Am Heart J. 2007 Jul;154(1):79.e1-7.

PMID:
17584556
13.

Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings.

Dohmann HF, Perin EC, Takiya CM, Silva GV, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Pascarelli BM, Assis IM, Dutra HS, Assad JA, Castello-Branco RV, Drummond C, Dohmann HJ, Willerson JT, Borojevic R.

Circulation. 2005 Jul 26;112(4):521-6. Epub 2005 Jul 18.

14.

Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.

Yao K, Huang R, Qian J, Cui J, Ge L, Li Y, Zhang F, Shi H, Huang D, Zhang S, Sun A, Zou Y, Ge J.

Heart. 2008 Sep;94(9):1147-53. doi: 10.1136/hrt.2007.137919. Epub 2008 Apr 1.

PMID:
18381377
15.

Autologous bone marrow cell transplantation combined with off-pump coronary artery bypass grafting in patients with ischemic cardiomyopathy.

Yoo KJ, Kim HO, Kwak YL, Kang SM, Jang YS, Lim SH, Hwang KC, Cho SW, Yang YS, Li RK, Kim BS.

Can J Surg. 2008 Aug;51(4):269-75.

16.

Transendocardial autologous bone marrow in myocardial infarction induced heart failure, two-year follow-up in an open-label phase I safety study (the TABMMI study).

de la Fuente LM, Stertzer SH, Argentieri J, Peñaloza E, Koziner B, Rouy D, Altman PA.

EuroIntervention. 2011 Nov;7(7):805-12. doi: 10.4244/EIJV7I7A127.

17.

Intracoronary administration of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathy.

Blatt A, Cotter G, Leitman M, Krakover R, Kaluski E, Milo-Cotter O, Resnick IB, Samuel S, Gozal D, Vered Z, Slavin S, Shapira MY.

Am Heart J. 2005 Nov;150(5):986.

PMID:
16290982
18.

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.

Perin EC, Willerson JT, Pepine CJ, Henry TD, Ellis SG, Zhao DX, Silva GV, Lai D, Thomas JD, Kronenberg MW, Martin AD, Anderson RD, Traverse JH, Penn MS, Anwaruddin S, Hatzopoulos AK, Gee AP, Taylor DA, Cogle CR, Smith D, Westbrook L, Chen J, Handberg E, Olson RE, Geither C, Bowman S, Francescon J, Baraniuk S, Piller LB, Simpson LM, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD; Cardiovascular Cell Therapy Research Network (CCTRN)..

JAMA. 2012 Apr 25;307(16):1717-26. doi: 10.1001/jama.2012.418. Epub 2012 Mar 24. Erratum in: JAMA. 2015 Jul 7;314(1):86.

19.

[A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].

Gu Y, Zhang J, Qi L.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2006 Oct;20(10):1017-20. Chinese.

PMID:
17140078
20.

Supplemental Content

Support Center